Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
about
Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitroResistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibilityEpigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.Hepatitis B virus resistance to lamivudine and its clinical implications.Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue.Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo.Fitness and infectivity of drug-resistant and cross-resistant hepatitis B virus mutants: why and how is it studied?Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.Intracellular antibody fragment against hepatitis B virus X protein does not inhibit viral replication.Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative.Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA.Novel role of 3-phosphoglycerate kinase, a glycolytic enzyme, in the activation of L-nucleoside analogs, a new class of anticancer and antiviral agents.
P2860
Q34105204-328C1190-C8C9-4A13-88C7-B92F94EA2D44Q34112556-C1BA284C-6A0D-4E66-A726-726CD8C0661AQ34299035-E0FD081A-02A0-43C2-9F49-9A47DA5D9FD2Q34366437-0A2BFE11-9150-40FD-9280-0E41EADD9707Q34756805-C6F77453-E001-4E3A-AC53-D36CC868F7D7Q35007583-6A44A31A-E567-47E1-AA38-19E51AB96F11Q35014297-7AFA8A7A-C4E3-47A0-BE56-ECDA64B6D196Q35850262-A03D7103-4060-4F4F-9E72-13384FE3ACBEQ36607389-6873FDEE-9AF4-4362-8844-680FECC4AE4AQ37762114-030B81A5-DFA0-45D5-9D85-68FD5DB2EC34Q38905804-3C3704B0-6343-4807-8E41-54041BCBEB71Q39652624-9A5551D8-0926-44D4-B035-DBAD7FC6A9ECQ40215340-D013DA3C-92F3-4D56-BB5D-35480E691160Q40400198-B8F6729A-8788-48F3-B2A5-C957DA6E1543Q43574111-722BBCC4-02CB-4649-BA01-14E97C00095AQ44517505-7B4B9ABC-EB15-4C2B-A5E5-D6F3CCC3A95E
P2860
Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of novel huma ...... d penciclovir-resistant virus.
@ast
Characterization of novel huma ...... d penciclovir-resistant virus.
@en
type
label
Characterization of novel huma ...... d penciclovir-resistant virus.
@ast
Characterization of novel huma ...... d penciclovir-resistant virus.
@en
prefLabel
Characterization of novel huma ...... d penciclovir-resistant virus.
@ast
Characterization of novel huma ...... d penciclovir-resistant virus.
@en
P2860
P4510
P1476
Characterization of novel huma ...... d penciclovir-resistant virus.
@en
P2860
P304
P356
10.1128/AAC.44.12.3402-3407.2000
P407
P577
2000-12-01T00:00:00Z